MissionIR Articles
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) to Report Q2 2020 Financial Results, Host Conference Call
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced plans to release its financial results for the second quarter ended June 30, 2020, after market close on Monday, July 27,…
-
Trxade Group Inc. (NASDAQ: MEDS) Pharmaceutical Platform May Save America’s Independent Pharmacies
The need for efficient drug procurement and delivery has never been more in demand Trxade Group’s unmatched supply chain trading platform represents a unique portal to speeding up drug distribution Such efficiencies are key to…
-
Trxade Group, Inc. (NASDAQ: MEDS) Telehealth App Incorporates New Educational Resources for Patients
Pharmaceutical and health care services company Trxade Group has added new tools to its Bonum Health telemedicine platform that will help patients better inform themselves about their medical needs and their provider’s prescription recommendations Trxade…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Achieves Exciting Capital Markets Milestone as It Hits the Russell Index
Trxade Group (NASDAQ: MEDS), an integrated drug and healthcare platform, was recently added to the Russell Microcap Index, which helps raise its profile among investors, furthering its reach to generate long-term shareholder value while limiting…
-
Trxade Group, Inc. (NASDAQ: MEDS) Invigorates Investors with Affirmative Presentation
Uplists to NASDAQ Added as component of Russell MicroCap Index Grew revenues 94% in 2019 Added 3,200 pharmacies in 2019 Total pharmacies on marketplace now number 11,400 Investors in Trxade Group (NASDAQ: MEDS) have received…
-
MissionIRNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Bonum Health Names New President
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, recently announced the appointment of Ashton Maaraba as president of Trxade Group’s Bonum Health telemedicine practice. An article discussing the company reads, “Maaraba…
-
Growing Independent Healthcare Platform Trxade Group, Inc. (NASDAQ: MEDS) Gains Inclusion on Russell Index for the Coming Year
Trxade Group Inc. facilitates the procurement and delivery of prescription drugs to a growing network of independent pharmacies, positioning them to compete with much larger national chains Trxade’s healthtech platform facilitates remote-access patient-provider consultations through…
-
Trxade Group, Inc. (NASDAQ: MEDS) Brings Taglich Brothers Onboard to Build Brand Reporting, Welcomes New Bonum Health President
Trxade Group Inc. is a growing B2B pharmaceutical network that provides solutions to small healthcare businesses, care providers and medical patients through growing optimization of remote-access health services Amid the sweep of the global COVID-19…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Selected for Inclusion on the Russell Microcap Index
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that it has been selected to be added to the Russell Microcap Index at the conclusion of the 2020 Russell indexes…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Building Parallel Network to Healthcare Chains Such as Walgreens or CVS
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, is building a parallel network to healthcare chains such as Walgreens or CVS by bringing together independent pharmacies across the country under its…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Coverage Initiated by Taglich Brothers
Coverage of Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, has been initiated by Taglich Brothers, Inc., a full-service broker dealer focused exclusively on microcap companies. Taglich Brothers offers institutional and…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Appoints Experienced Healthcare Executive as President of Its Emerging Telemedicine Platform
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, recently announced that Ashton Maaraba is joining the Company as President of Bonum Health, Trxade Group’s telemedicine practice. According to the update, Maaraba…
-
Trxade Group Inc.’s (NASDAQ: MEDS) Pharmaceutical Marketplace Continues Profitable Expansion
Revenues for Q1 2020 up 46% year over year Gross profit of 75% shows viability of business model Close to 12,000 independent pharmacies now using online marketplace Stellar results recently reported by Trxade Group Inc.…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Plans to Present at the June 2020 Virtual Investor Summit
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the June 2020 Virtual Investor Summit slated to take place June 9-12, 2020. According to the…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Providing Premium Medical Teleconferences
Trxade Group (NASDAQ: MEDS), through its virtual healthcare subsidiary Bonum Health, provides telehealth services and prescription ordering via teleconferences that are conducted using smart devices. A recent article discussing the company reads, “The service provides…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Subsidiary Providing COVID-19 Antibody Testing for Commercial Property Firm in Atlanta
Trxade Group (NASDAQ: MEDS) and its wholly owned subsidiary, Integra Pharma Solutions, were recently featured in a CoStar.com article titled ‘Lee & Associates Atlanta to Reopen Office Monday, Offer Coronavirus Antibody Testing’. The article reports…
-
Trxade Group Inc. (NASDAQ: MEDS) Anticipates Successful Year Despite Pandemic, Building on 2019 Growth
Trxade Group Inc.’s technologically nimble health care platform and network help community-based pharmaceuticals meet the challenges of providing medications and medical consultation at lowering costs with efficiency and operational transparency The company’s year-end financial statement…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Featured in Dougherty & Company LLC Research Report
Trxade Group Inc. (NASDAQ: MEDS) was featured in a recent equity research report published by Dougherty & Company LLC. The report reads, “We reiterate our Buy rating and $12 Price Target on MEDS following Q1…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Releases Q1 2020 Financial Results
Trxade Group, Inc. (NASDAQ: MEDS), an integrated telehealth, drug procurement, delivery and online healthcare marketplace, today reported its financial results for the first quarter ended March 31, 2020. Among the highlights, Trxade reported a 46%…
-
MissionIRNewsBreaks – Trxade Group, Inc.’s (NASDAQ: MEDS) Integral Role in Efforts to Combat COVID-19 Featured in NetworkNewsAudio Podcast
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, was featured in an exclusive NetworkNewsWire (“NNW”) audio podcast, via NNW’s audio press release solutions suite. The podcast contains NNW editorial coverage…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Pivotal Moment on Path to 2026 Rare Earth Oxide Production
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Marks Bold Entry Into the Growing Battery Storage Market with 4.99 MW BESS in Ontario
- Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy
- New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Eyes Bolivia’s Untapped Silver Potential Amid Global Supply Gaps
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial